George Bourikas

1.2k total citations · 1 hit paper
21 papers, 776 citations indexed

About

George Bourikas is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, George Bourikas has authored 21 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 8 papers in Hematology and 8 papers in Immunology. Recurrent topics in George Bourikas's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). George Bourikas is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). George Bourikas collaborates with scholars based in Greece, United Kingdom and France. George Bourikas's co-authors include Melvyn F. Greaves, J. M. Bridges, Irvin A. Lampert, A. W. G. Goolden, Alison Brownell, M Rose, William A. Blattner, D. A. G. Galton, D R McCluskey and Robin Ireland and has published in prestigious journals such as The Lancet, Blood and Leukemia.

In The Last Decade

George Bourikas

21 papers receiving 724 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES

1982 399 citations D Catovsky, M Rose et al. The Lancet profile →

Peers

Countries citing papers authored by George Bourikas

Since Specialization

Citations

This map shows the geographic impact of George Bourikas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Bourikas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Bourikas more than expected).

Fields of papers citing papers by George Bourikas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Bourikas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Bourikas. The network helps show where George Bourikas may publish in the future.

Co-authorship network of co-authors of George Bourikas

This figure shows the co-authorship network connecting the top 25 collaborators of George Bourikas. A scholar is included among the top collaborators of George Bourikas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Bourikas. George Bourikas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2<sup>V617F</sup> Mutation Status 2011 ·Acta Haematologica ·(unknown), Costas Tsatalas, Konstantinos Anagnostopoulos, Grigorios Trypsianis, (unknown), (unknown), (unknown), Emmanouil Spanoudakis, Ιoannis Kotsianidis, Dimitrios Margaritis, Alexandros Kortsaris, George Bourikas	4
2	Th17 and Foxp3+ T regulatory cell dynamics and distribution in myelodysplastic syndromes 2011 ·Clinical Immunology ·Irene Bouchliou, (unknown), Evangelia Nakou, Emmanouil Spanoudakis, (unknown), Sofia Vakalopoulou, (unknown), (unknown), George Bourikas, Costas Tsatalas, Ιoannis Kotsianidis	42
3	Partial versus Productive Immunoglobulin Heavy Locus Rearrangements in Chronic Lymphocytic Leukemia: Implications for B-Cell Receptor Stereotypy 2011 ·Molecular Medicine ·(unknown), (unknown), (unknown), Thorsten Raff, Antonis Dagklis, (unknown), Tatjana Smilevska, George Bourikas, Hélène Merle‐Béral, (unknown), Αchilles Anagnostopoulos, Monika Brüggemann, Frédéric Davi, Κώστας Σταματόπουλος, Chrysoula Belessi	9
4	Oxidised low‐density lipoprotein and arterial function in β‐thalassemia major 2009 ·European Journal Of Haematology ·Dimitrios Stakos, Anna Tavridou, Dimitrios Margaritis, Dimitrios Tziakas, Ιoannis Kotsianidis, Georgios Chalikias, (unknown), George Bourikas, Vangelis G. Manolopoulos, Harisios Boudoulas	11
5	Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation 2008 ·Leukemia Research ·Emmanouil Spanoudakis, Dimitrios Margaritis, Ιoannis Kotsianidis, George Georgiou, G. Tripsianis, (unknown), (unknown), (unknown), Panayiotis Panayiotidis, George Bourikas, Costas Tsatalas	1
6	In vitro Effects of the Farnesyltransferase Inhibitor Tipifarnib on Myelodysplastic Syndrome Progenitors 2008 ·Acta Haematologica ·Ιoannis Kotsianidis, (unknown), (unknown), Emmanouil Spanoudakis, (unknown), Dimitrios Margaritis, George Bourikas, R. De Coster, Peter De Porre, Costas Tsatalas	2
7	Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients 2008 ·Annals of Hematology ·Emmanouil Spanoudakis, (unknown), Ιoannis Kotsianidis, Dimitrios Margaritis, (unknown), Anna Christoforidou, Costas Tsatalas, George Bourikas	13
8	Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS) 2008 ·Leukemia ·Ιoannis Kotsianidis, Irene Bouchliou, Evangelia Nakou, (unknown), Dimitrios Margaritis, Anna V. Christophoridou, (unknown), Christina Tsigalou, George Bourikas, Anastasios Karadimitris, C. Tsatalas	108
9	Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy 2008 ·Acta Haematologica ·Anna Christoforidou, (unknown), (unknown), (unknown), Dimitrios Margaritis, Ιoannis Kotsianidis, (unknown), V. Kaloutsi, George Bourikas, Costas Tsatalas	12
10	Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells 2005 ·Blood ·Ιoannis Kotsianidis, Jonathan D. Silk, Emmanouil Spanoudakis, Scott D. Patterson, António Almeida, Richard R. Schmidt, Costas Tsatalas, George Bourikas, Vincenzo Cerundolo, Irene Roberts, Anastasios Karadimitris	30
11	Effect of 4 weeks of basic military training on peripheral blood leucocytes and urinary excretion of catecholamines and cortisol 2005 ·Journal of Sports Sciences ·Polyzois Makras, George Koukoulis, George Bourikas, George Papatheodorou, (unknown), Panagiotis G. Menounos, (unknown), G Kartalis	29
12	Regulation of Hematopoiesis In Vitro and In Vivo by Invariant NKT Cells. 2005 ·Blood ·Ιoannis Kotsianidis, Jonathan D. Silk, Scott D. Patterson, António Almeida, Costas Tsatalas, George Bourikas, Vincenzo Cerundolo, Irene Roberts, Anastasios Karadimitris	1
13	Extramedullary plasmacytoma: report of two cases with uncommon presentation 2004 ·Annals of Hematology ·(unknown), C. Tsatalas, Dimitrios Margaritis, Anastasios J. Karayiannakis, V. Kaloutsi, (unknown), (unknown), (unknown), Efthimios Sivridis, George Bourikas	7
14	Amifostine Stimulates the Formation of Hematopoietic Bone Marrow Progenitors from B-Cell Chronic Lymphocytic Leukemia 2004 ·Acta Haematologica ·Costas Tsatalas, (unknown), (unknown), (unknown), Ιoannis Kotsianidis, (unknown), Gregory Tripsianis, (unknown), Zafiris Kartasis, (unknown), George Bourikas	2
15	Splenectomy for Massive Splenic Infarction Unmasks Paroxysmal Nocturnal Hemoglobinuria 2003 ·Acta Haematologica ·Costas Tsatalas, (unknown), (unknown), Ιoannis Kotsianidis, Anastasios J. Karayiannakis, (unknown), Zafiris Kartasis, (unknown), Alexandros Polychronidis, (unknown), George Bourikas	10
16	Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95/Fas and CD31 expressing T-cells, in breast cancer patients 2003 ·Cancer Immunology Immunotherapy ·Michael I. Koukourakis, (unknown), George Bourikas, G Kartalis, Costas Tsatalas	16
17	Efficacy of Lamivudine in Patients with Hematologic Malignancies Receiving Chemotherapy and Precore Mutant Chronic Active Hepatitis B 2002 ·Acta Haematologica ·(unknown), Costas Tsatalas, (unknown), (unknown), (unknown), Stamatia Kotsiou, G Kartalis, George Bourikas	9
18	Successful Treatment of Angioimmunoblastic Lymphadenopathy with Dysproteinemia-Type T-Cell Lymphoma with Fludarabine 2001 ·Acta Haematologica ·Costas Tsatalas, (unknown), (unknown), (unknown), Ιoannis Kotsianidis, George Bourikas	15
19	The Membrane Phenotype of T‐Prolymphocytic Leukaemia 1982 ·Scandinavian Journal of Haematology ·Daniel Catovsky, (unknown), E Matutes, R. Ariel Gómez, George Bourikas, Maria Valeria Cherchi, (unknown), M B Pepys, T Kitani, A. Victor Hoffbrand, Melvyn F. Greaves	37
20	ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES breakdown → 1982 ·The Lancet ·D Catovsky, M Rose, A. W. G. Goolden, (unknown), George Bourikas, Alison Brownell, William A. Blattner, Melvyn F. Greaves, D. A. G. Galton, D R McCluskey, Irvin A. Lampert, Robin Ireland, J. M. Bridges, Robert C. Gallo	399

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact